Title
Category
Credits
Event date
Cost
Why Do Smart People Make Mistakes? The Answers are Worthy of a Nobel Prize
  • Behavioral health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Participants in this activity will learn about the system framework theory of decision-making and how System I- and System II-type cognitive processes can best be utilized in the health care setting. The role of heuristics (mental “shortcuts” and rules-of-thumb) will be examined, as well as the types of cognitive biases (inherent and often unconscious systematic errors in thinking) that most commonly result in negative health outcomes. Debiasing strategies to address these negative influences on rational and optimal decision-making that are applicable to the self and the health care team will be explored. 
CMS HEDIS and Stars Pharmacy Overview—Medication Adherence, Statin Use in Patients and More
  • Disease management
  • 2.00 ACPE - Pharmacists
  • 2.00 ACPE - Pharmacy Technicians
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 APA - Psychologists
  • 2.00 Attendance - General Attendance
  • 2.00 ASWB - Social Workers
$0.00
Participants in this activity will learn how CMS measures medication adherence, its role in patient qualification status, impact on claims algorithms, and potential caveats of these determinations. Strategies to address common barriers to medication adherence will be discussed, along with best practices that may improve adherence. In addition, the five measures included in the 2021 Medicare Part D star ratings, including those regarding medication adherence for diabetes, hypertension, cholesterol, as well as statin use in persons with diabetes, will be reviewed.
What’s Special about Specialty Pharmacy?
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This session examines the cost of development and growth of these pharmaceuticals and details the specific role that specialty pharmacy plays in making these products accessible. The high costs of therapies and patient and medication management are also discussed along with the role and value of drug benefit programs.
Chronic Kidney Disease, Metabolic and Cardiovascular Disease: Insights into Present and Future Treatment
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity examines current data about chronic kidney disease (CKD), including its health outcomes and relationships with cardiovascular and metabolic disease. Treatment regimens aimed at delaying progression and their outcomes are reviewed, along with current knowledge regarding the pathophysiologic and genetic basis of this disease. Areas of emerging interest in research on potential new treatments targeting the causes of CKD are discussed, including genomic analysis, and their relevance to clinical care.
Transition of Care: Our Patients Are Growing Up
  • Disease management
  • Pediatrics
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity provides a thorough understanding of the recommended health care transition (HCT) components, considerations and goals that should be constant across HCT planning. It discusses the importance of coordinating the efforts of the health care team, adolescent and family to ensure continuity of care, positive health outcomes, and optimal quality of life.
Medical Director and Clinician Leadership Forum 2023
  • Transplantation
  • 5.50 ACPE - Pharmacists
  • 5.50 ACPE - Pharmacy Technicians
  • 5.50 AMA - Physicians
  • 5.50 ANCC - Nurses
  • 5.50 APA - Psychologists
  • 5.50 Attendance - General Attendance
  • 5.50 CDR - Dietitians
  • 5.50 ASWB - Social Workers
$0.00
The Medical Director and Clinician Leadership Forum is designed to bring medical directors and other executive clinical leaders together to learn from nationally recognized practitioners and thought leaders. Faculty will share their insights into topics that are critical to the management of large patient populations.
Current Opioid Prescribing Guidelines: Ensuring Safe and Effective Pain Management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
Clinical practice guidelines are used in health care as an educational tool to improve patient care as a potential solution to reduce inappropriate variations in care. Opioid prescribing guidelines provide clear and comprehensive, evidence-based recommendations incorporating current information and practices for practitioners. This activity will examine the scope, impact, key statistics and factors contributing to the opioid crisis and highlight the current recommended opioid prescribing guidelines, their challenges and the role of state prescription drug monitoring programs (PDMP). Strategies to aid in implementing the opioid prescribing guidelines and to mitigate the opioid crisis will also be discussed.
Creating Space for Complex Conversations with Patients Experiencing Life-Changing Illnesses
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Caring for patients with complex medical conditions can be emotionally challenging for health care providers, particularly when difficult conversations need to be had with patients and their loved ones. This session will explore complex grief, its symptoms, and how health care professionals can recognize it in themselves and their patients, as well as provide strategies for managing grief and supporting patients and families.
Optimizing Patient-Reported Outcomes for Enhanced Quality, Experience and Decision-Making in Health Care
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Patient-reported outcomes (PRO) are crucial in evaluating the impact of health care professionals, teams, and systems on patients’ health, quality of life, and treatment outcomes. By consistently tracking PRO scores, health care organizations can pinpoint areas of excellence and opportunities for improvement, as well as compare the effectiveness of different treatment options. This presentation will explore the benefits of PRO measures in health care and provide insights on how to seamlessly integrate these measures into clinical practice. Strategies for interpreting and utilizing PRO data to improve health care quality will also be highlighted.
CRISPR-Based Therapies for Genetic Blood Disorders
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Join this session to explore updates in genetic therapy for two prevalent hemaglobinopathies: sickle cell disease and beta thalassemia.

Pages